Brugnoli, F., Grassilli, S., Lanuti, P., Marchisio, M., Al-Qassab, Y., Vezzali, F., . . . Bertagnolo, V. (2017). Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133(+)/EpCAM(+) phenotype: A promising target for preventing progression of TNBC. BMC Cancer.

Brugnoli, Federica, Silvia Grassilli, Paola Lanuti, Marco Marchisio, Yasamin Al-Qassab, Federica Vezzali, Silvano Capitani, and Valeria Bertagnolo. "Up-modulation of PLC-β2 Reduces the Number and Malignancy of Triple-negative Breast Tumor Cells With a CD133(+)/EpCAM(+) Phenotype: A Promising Target for Preventing Progression of TNBC." BMC Cancer 2017.

Brugnoli, Federica, et al. "Up-modulation of PLC-β2 Reduces the Number and Malignancy of Triple-negative Breast Tumor Cells With a CD133(+)/EpCAM(+) Phenotype: A Promising Target for Preventing Progression of TNBC." BMC Cancer 2017.